1. Home
  2. FCUV vs CYTH Comparison

FCUV vs CYTH Comparison

Compare FCUV & CYTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCUV
  • CYTH
  • Stock Information
  • Founded
  • FCUV 2012
  • CYTH 1990
  • Country
  • FCUV United States
  • CYTH United States
  • Employees
  • FCUV N/A
  • CYTH N/A
  • Industry
  • FCUV Industrial Machinery/Components
  • CYTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • FCUV Industrials
  • CYTH Health Care
  • Exchange
  • FCUV Nasdaq
  • CYTH Nasdaq
  • Market Cap
  • FCUV 19.9M
  • CYTH 20.4M
  • IPO Year
  • FCUV N/A
  • CYTH N/A
  • Fundamental
  • Price
  • FCUV $0.22
  • CYTH $0.66
  • Analyst Decision
  • FCUV
  • CYTH Buy
  • Analyst Count
  • FCUV 0
  • CYTH 3
  • Target Price
  • FCUV N/A
  • CYTH $0.95
  • AVG Volume (30 Days)
  • FCUV 204.3K
  • CYTH 41.7K
  • Earning Date
  • FCUV 11-07-2024
  • CYTH 11-14-2024
  • Dividend Yield
  • FCUV N/A
  • CYTH N/A
  • EPS Growth
  • FCUV N/A
  • CYTH N/A
  • EPS
  • FCUV N/A
  • CYTH N/A
  • Revenue
  • FCUV $1,078,349.00
  • CYTH $870,725.00
  • Revenue This Year
  • FCUV N/A
  • CYTH N/A
  • Revenue Next Year
  • FCUV N/A
  • CYTH $24.49
  • P/E Ratio
  • FCUV N/A
  • CYTH N/A
  • Revenue Growth
  • FCUV 247.90
  • CYTH N/A
  • 52 Week Low
  • FCUV $0.15
  • CYTH $0.57
  • 52 Week High
  • FCUV $1.80
  • CYTH $2.12
  • Technical
  • Relative Strength Index (RSI)
  • FCUV 38.01
  • CYTH 47.76
  • Support Level
  • FCUV $0.22
  • CYTH $0.60
  • Resistance Level
  • FCUV $0.27
  • CYTH $0.66
  • Average True Range (ATR)
  • FCUV 0.02
  • CYTH 0.05
  • MACD
  • FCUV -0.00
  • CYTH 0.00
  • Stochastic Oscillator
  • FCUV 2.21
  • CYTH 46.67

About FCUV Focus Universal Inc.

Focus Universal Inc develops and manufactures universal smart devices. Its product portfolio includes Universal Smart Instrumentation Platform, Ubiquitor, Universal Smart Controller, and Sensors. The company also supplies various air filtration systems. The Company consists of three types of operations- Focus and Focus Shenzhen (Corporate), Perfecular and Lusher (IoT Products), and AVX (IoT Installation Services). The majority of revenue is generated from IoT Installation Services. IoT Installation Services segment is an IoT installation and management company specializing in high-performance and easy-to-use audio/video, home theater, lighting control, automation, and integration.

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

Share on Social Networks: